tiprankstipranks
Advertisement
Advertisement

INCY Stock Latest News

Incyte’s POD1UM-204 Endometrial Cancer Study Wraps Up, Setting the Stage for Key Retifanlimab Data
Company AnnouncementsIncyte’s POD1UM-204 Endometrial Cancer Study Wraps Up, Setting the Stage for Key Retifanlimab Data
1d ago
INCY
Incyte Shareholders Back Board, Pay and Auditor Choices
PremiumCompany Announcements
Incyte Shareholders Back Board, Pay and Auditor Choices
3d ago
8K
INCY
Incyte Upgraded on Vega Acquisition Synergies as Analyst Raises Price Target to $140 and Reiterates Buy
PremiumRatings
Incyte Upgraded on Vega Acquisition Synergies as Analyst Raises Price Target to $140 and Reiterates Buy
3d ago
INCY
Incyte price target raised to $107 from $90 at Oppenheimer
PremiumThe Fly
Incyte price target raised to $107 from $90 at Oppenheimer
4d ago
INCY
Jefferies sees positive readthroughs to Hemab Therapeutics from Incyte deal
PremiumThe Fly
Jefferies sees positive readthroughs to Hemab Therapeutics from Incyte deal
4d ago
COAG
INCY
Incyte to Acquire Vega Therapeutics in $2B Deal
PremiumCompany AnnouncementsIncyte to Acquire Vega Therapeutics in $2B Deal
5d ago
8K
INCY
Incyte to acquire Vega Therapeutics for $1.25B
Premium
The Fly
Incyte to acquire Vega Therapeutics for $1.25B
5d ago
INCY
Incyte, Mirum to present Phase 2 results from PROGRESS study at ENDO 2026
Premium
The Fly
Incyte, Mirum to present Phase 2 results from PROGRESS study at ENDO 2026
9d ago
INCY
MIRM
Incyte Advances Early-Stage Skin Drug Study, Supporting Long-Term Growth Story
PremiumCompany Announcements
Incyte Advances Early-Stage Skin Drug Study, Supporting Long-Term Growth Story
9d ago
INCY
Incyte Buy Rating Reiterated as Analyst Highlights Robust Pipeline, Clinical Catalysts and Maintains $124 Price Target
PremiumRatings
Incyte Buy Rating Reiterated as Analyst Highlights Robust Pipeline, Clinical Catalysts and Maintains $124 Price Target
12d ago
INCY
Incyte Buy Rating Reiterated as Monjuvi Data Support Diversification; $135 Price Target Maintained
PremiumRatings
Incyte Buy Rating Reiterated as Monjuvi Data Support Diversification; $135 Price Target Maintained
12d ago
INCY
Incyte announces results from Phase 3 frontMIND trial on tafasitamab
PremiumThe Fly
Incyte announces results from Phase 3 frontMIND trial on tafasitamab
12d ago
INCY
Wedbush bullish on Damora Therapeutics, initiates with an Outperform
PremiumThe FlyWedbush bullish on Damora Therapeutics, initiates with an Outperform
15d ago
DMRA
INCY
Incyte’s Ruxolitinib Cream Delivers Strong Phase 3b Eczema Data, Supporting Dermatology Upside for INCY
Premium
Company Announcements
Incyte’s Ruxolitinib Cream Delivers Strong Phase 3b Eczema Data, Supporting Dermatology Upside for INCY
21d ago
INCY
Bernstein starts Incyte at MarketPerform, sees no clear path for revenue rebound
Premium
The Fly
Bernstein starts Incyte at MarketPerform, sees no clear path for revenue rebound
22d ago
INCY
Incyte initiated with a Market Perform at Bernstein
PremiumThe Fly
Incyte initiated with a Market Perform at Bernstein
22d ago
INCY
Incyte, Genesis Molecular AI announce expansion of collaboration
PremiumThe Fly
Incyte, Genesis Molecular AI announce expansion of collaboration
24d ago
INCY
Incyte, Edison Scientific announce strategic collaboration to employ Kosmos
PremiumThe Fly
Incyte, Edison Scientific announce strategic collaboration to employ Kosmos
25d ago
INCY
Incyte Targets KRAS G12D Pancreatic Cancer With New Phase 3 DAWN-303 Trial
PremiumCompany Announcements
Incyte Targets KRAS G12D Pancreatic Cancer With New Phase 3 DAWN-303 Trial
1M ago
INCY
Incyte announces 24-week long-term data from Phase 3 TRuE-AD4 trial
PremiumThe FlyIncyte announces 24-week long-term data from Phase 3 TRuE-AD4 trial
1M ago
INCY
Incyte gets orphan designation for treatment of pancreatic cancer
Premium
The Fly
Incyte gets orphan designation for treatment of pancreatic cancer
1M ago
INCY
MacroGenics, Sagard enter expanded Zynyz royalty purchase agreement
Premium
The Fly
MacroGenics, Sagard enter expanded Zynyz royalty purchase agreement
1M ago
INCY
MGNX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >